UB069
TargetsRIPK1
IndicationsPeripheral arterial disease; Primary biliary cholangitis
ClinicalCN - I
TherapeuticsCardiovascular; Gastroenterology & Hepatology
ModalitiesSmall Molecule
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →